Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rhee

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
Annals of Surgical Oncology|June 14, 2023
Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)Abigail I Wald, James F Pingpank, Melanie Ongchin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 8, 2020
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapyLaura A Favazza, Christine M Parseghian, Cihan Kaya, et al.
Digestive Diseases and Sciences|January 18, 2006
Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) StudyY-H Kim, J H Lee, S K Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 10, 2024
Incidence and mortality of sepsis in Hong Kong between 2009 and 2018 based on electronic health records: abridged secondary publicationL Ling, J Z Zhang, L C Chang, et al.
The Oncologist|October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Annals of Surgical Oncology|February 1, 2021
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves SurvivalRichard S Hoehn, Caroline J Rieser, Sharon Winters, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 5, 2020
Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient OutcomeRohit Das, Kevin McGrath, Natalie Seiser, et al.
Cancer|October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Annals of Surgical Oncology|June 14, 2023
Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)Abigail I Wald, James F Pingpank, Melanie Ongchin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 8, 2020
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapyLaura A Favazza, Christine M Parseghian, Cihan Kaya, et al.
Digestive Diseases and Sciences|January 18, 2006
Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) StudyY-H Kim, J H Lee, S K Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 10, 2024
Incidence and mortality of sepsis in Hong Kong between 2009 and 2018 based on electronic health records: abridged secondary publicationL Ling, J Z Zhang, L C Chang, et al.
The Oncologist|October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Annals of Surgical Oncology|February 1, 2021
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves SurvivalRichard S Hoehn, Caroline J Rieser, Sharon Winters, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 5, 2020
Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient OutcomeRohit Das, Kevin McGrath, Natalie Seiser, et al.
Cancer|October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
Pageof 21